Most EOR vs entity guides ignore what really matters for biotech. The standard cost and speed comparison breaks down once you factor in clinical trial sponsorship, FDA submissions, SBIR eligibility, R&D tax credits, and senior hire equity. Here is the 2026 framework that actually applies to international life science companies.
